NPI registry status
Active
2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1326208513 MD
Verify on CMS → Lubna Mirza, MD
Endocrinology, Diabetes & Metabolism Physician in Norman, Oklahoma.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 7,871 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
3K
Medicare Part D claims · 486 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
45%
generic claims · 48% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
91.2/100
▲ 8 pts above national avg 83.5 · Exceptional
Industry payments
$2.2K
72 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Lubna Mirza, MD reported a CMS MIPS final score of 91.2/100 - above the 83.5 national average - and filed 2,757 Medicare Part D claims in 2023.
- 91.2/100
- MIPS score · +8 vs avg
- 3K
- Part D claims, 2023
- 45%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Lubna Mirza, MD
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1326208513), first enumerated 06/11/2008.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 2,757 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 91.2/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
3 CMS Care Compare hospital affiliations on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$2.2K in reported industry payments (72 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1326208513 · Endocrinology, Diabetes & Metabolism Physician
NPI-10 · ENUM-MID · TAX-MID · MIPS-ABOVE · RX-MID · BOOK-THIN · PHOTO-FINISH
- NPI-10 1326208513
- ENUM-MID 2008
- TAX-MID 8K Endocrinology, Diabetes
- MIPS-ABOVE 91.2/100
- RX-MID 2,757
- BOOK-THIN 61 in Oklahoma
- PHOTO-FINISH Allison Kerr · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Mirza · this pro…
Mirza · this provider
91.2 MIPS pts
- Allison Kerr · n…
Allison Kerr
91.2 MIPS pts
- Varvara Alexiadi…
Varvara Alexiadis
91.3 MIPS pts
- Zinoviy Abelev ·…
Zinoviy Abelev
91.3 MIPS pts
- Naim Abrar · near
Naim Abrar
91.3 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Lubna Mirza, MD's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
91 ≥ 61st percentile 61% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Lubna Mirza, MD sits
This provider among endocrinology, diabetes & metabolism physician peers
Across the 2,341 endocrinology, diabetes & metabolism physician providers who report both Medicare Part D prescribing and a MIPS quality score, Lubna Mirza, MD writes more Part D claims than 56% of them and scores higher on MIPS quality than 63% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one endocrinology, diabetes & metabolism physician peer from a representative sample of 60; the gold marker is Lubna Mirza, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Lubna Mirza, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 3 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Lubna Mirza, MD?
High performer (top quartile)Primary specialty
Endocrinology, Diabetes & Metabolism Physician
Medicare Part D claims
2,757 4% vs specialty avg
MIPS final score
91.2/100 7.7 pts vs avg
Specialty distribution in Oklahoma
How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Oklahoma providers
Medicare quality performance, MIPS
Lubna Mirza, MD's 2023 MIPS final score plotted against the Endocrinology, Diabetes & Metabolism Physician national average
- MIPS Final Score
- 91.2/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1326208513 |
|---|---|
| Specialty | Endocrinology, Diabetes & Metabolism Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 06/11/2008 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
91.1858
Final Score
Measured-score avg: 83.5
79.2714
Quality
100
Promoting Interoperability
Reporting: Alternative Payment Model
Hospital and facility affiliations
Facilities where Lubna Mirza, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
According to CMS billing records, Lubna Mirza, MD is affiliated with 3 Medicare-billing facilities.
Central Oklahoma Family Medical Center Inc
Ada, OK
Mirza Endocrinology LLC
Norman, OK
Norman Regional Providers Specialty Care
Norman, OK
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Lubna Mirza, MD. Source: openpaymentsdata.cms.gov.
Total received
$2.2K
Largest payer
Tandem Diabetes Care, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Above average
Lubna Mirza, MD - brand share 48.0%
Endocrinology, Diabetes & Metabolism Physician average
48% brand-name claims vs 45% generic, on 2,757 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
2,757
Total Claims
$1.8M
Total Drug Cost
486
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 6,930
- Total Day Supply
- 206,226
- Brand vs Generic
- 48% brand / 45% generic
- Brand Drug Cost
- $1.7M
- Generic Drug Cost
- $41K
Patient Demographics
- Average Patient Age
- 68.8 years
- Avg HCC Risk Score
- 1.56
- Gender Split
- 69% female / 31% male
- Age Distribution
- <65: 110, 65-74: 234, 75-84: 130, 85+: 12
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Lubna Mirza, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Levothyroxine Sodium
Levothyroxine Sodium
583 claims
- Metformin Hcl 132
Metformin Hcl
132 claims
- Trulicity 121
Trulicity
121 claims
- Alendronate Sodium 96
Alendronate Sodium
96 claims
- Tresiba Flextouch … 86
Tresiba Flextouch U-200
86 claims
- Atorvastatin Calcium 84
Atorvastatin Calcium
84 claims
- Ozempic 84
Ozempic
84 claims
- Jardiance 78
Jardiance
78 claims
| Drug | Claims |
|---|---|
| Levothyroxine Sodium | 583 |
| Metformin Hcl | 132 |
| Trulicity Dulaglutide | 121 |
| Alendronate Sodium | 96 |
| Tresiba Flextouch U-200 Insulin Degludec | 86 |
| Atorvastatin Calcium | 84 |
| Ozempic Semaglutide | 84 |
| Jardiance Empagliflozin | 78 |
| Metformin Hcl Er Metformin Hcl | 60 |
| Methimazole | 58 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Endocrinology, Diabetes & Metabolism Physician in OK →
All providers in Oklahoma →
Compare specialties →
Endocrinology, Diabetes & Metabolism Physician Overview
How Lubna Mirza, MD fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.
7,871
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider
Lubna Mirza, MD's 2,757 claims are above the specialty average of 2,639.
Nationwide Endocrinology, Diabetes & Metabolism Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Mirza, both outside Oklahoma so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (91.2 here).
Same NPPES enumeration year (2008)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Oklahoma
Other clinicians with the same primary specialty enrolled in Oklahoma, drawn from the same CMS NPPES roster as Mirza.
One of 61 Endocrinology, Diabetes & Metabolism Physician providers enrolled in Oklahoma, 5 are shown here.
Dr. Elie Abed
M.D.
Tulsa, OK
Dr. Vaqar Ahmad
MD
Midwest City, OK
Dr. Hamsa Aljumaili
MD
Oklahoma City, OK
Dr. Bassam Arodak
MD
Oklahoma City, OK
Dr. Donald Aspenson
M.D.
Tulsa, OK
Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Lubna Mirza, MD's specialty? ▼
Lubna Mirza, MD specializes in Endocrinology, Diabetes & Metabolism Physician and practices in Norman, Oklahoma. Credentials: MD.
How much does Lubna Mirza, MD prescribe under Medicare Part D? ▼
In 2023, Lubna Mirza, MD wrote 2,757 Medicare Part D claims totaling $1.8M in drug costs for 486 beneficiaries.
What is Lubna Mirza, MD's Medicare quality score? ▼
Lubna Mirza, MD has a CMS MIPS Final Score of 91.2/100 (Quality: 79.3). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Lubna Mirza, MD located? ▼
Lubna Mirza, MD is located at 800 WALL ST, Norman, OK, 73069. Phone: (405) 857-7254.
What is Lubna Mirza, MD's NPI number? ▼
Lubna Mirza, MD's National Provider Identifier (NPI) is 1326208513, issued on 06/11/2008.
Does Lubna Mirza, MD prescribe more brand-name or generic drugs? ▼
Lubna Mirza, MD's prescribing is 48% brand-name and 45% generic drugs by claim count, with $1.7M in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US? ▼
There are 7,871 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does Lubna Mirza, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, Lubna Mirza, MD's most frequently prescribed drugs include Levothyroxine Sodium, Metformin Hcl, Trulicity. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Lubna Mirza, MD accept Medicare? ▼
Lubna Mirza, MD appears in CMS Medicare data with 2,757 Part D claims and 486 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Lubna Mirza, MD's credentials? ▼
Lubna Mirza, MD's NPI is 1326208513 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.